Trial Profile
Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Sep 2009
Price :
$35
*
At a glance
- Drugs Bisoprolol (Primary) ; Fluvastatin (Primary)
- Indications Cardiovascular disorders; Myocardial infarction; Perioperative ischaemia
- Focus Therapeutic Use
- Acronyms DECREASE-IV
- 01 Jun 2009 Status changed from recruiting to completed, according to published results.
- 21 Feb 2007 New trial record.